We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$9.8B
AUM Growth
-$1.96B
(-17%)
Cap. Flow
-$53.6M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
15.05%
Holding
1,967
New
854
Increased
344
Reduced
350
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$97.9M |
| 2 |
SHPG
Shire pic
SHPG
|
+$80.3M |
| 3 |
Teleflex
TFX
|
+$76.7M |
| 4 |
Accenture
ACN
|
+$74.6M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$74.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$140M |
| 2 |
Quest Diagnostics
DGX
|
+$97.7M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$94.3M |
| 4 |
Tractor Supply
TSCO
|
+$78.2M |
| 5 |
AET
Aetna Inc
AET
|
+$77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.48% |
| 2 | Consumer Discretionary | 18.77% |
| 3 | Technology | 12.96% |
| 4 | Financials | 11.62% |
| 5 | Industrials | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
NewtekOne
NEWT
$424M
| $1.65M | 0.02% |
+94,289
| New | +$1.82M |
|
777
Medifast
MED
$106M
| $1.64M | 0.02% |
+13,101
| New | +$2.24M |
|
778
Regenxbio
RGNX
$644M
| $1.63M | 0.02% |
38,821
-317,965
| -89% | -$18.7M |
|
779
Thor Industries
THO
$4.09B
| $1.63M | 0.02% |
31,317
-1,078,964
| -97% | -$73M |
|
|
CELG
780
DELISTED
Celgene Corp
CELG
| $1.63M | 0.02% |
25,355
-257,717
| -91% | -$19M |
|
|
NSU
781
DELISTED
Nevsun Resources Ltd.
NSU
| $1.61M | 0.02% |
+367,800
| New | +$1.63M |
|
|
MTSC
782
DELISTED
MTS Systems Corp
MTSC
| $1.61M | 0.02% |
+40,230
| New | +$1.94M |
|
|
DX
783
Dynex Capital
DX
$3.02B
| $1.61M | 0.02% |
+93,878
| New | +$1.68M |
|
784
Axalta
AXTA
$7.25B
| $1.59M | 0.02% |
+67,889
| New | +$1.69M |
|
785
Houlihan Lokey
HLI
$9.82B
| $1.58M | 0.02% |
42,946
+3,300
| +8% | +$135K |
|
786
Arbor Realty Trust
ABR
$975M
| $1.58M | 0.02% |
+156,860
| New | +$1.82M |
|
787
Commault Systems
CVLT
$6.13B
| $1.58M | 0.02% |
+26,691
| New | +$1.57M |
|
|
HTO
788
H2O America
HTO
$2.68B
| $1.58M | 0.02% |
+28,324
| New | +$1.68M |
|
789
Shinhan Financial Group
SHG
$33.7B
| $1.57M | 0.02% |
+44,234
| New | +$1.67M |
|
|
WMGI
790
DELISTED
Wright Medical Group Inc
WMGI
| $1.56M | 0.02% |
57,192
-1,711,387
| -97% | -$47.3M |
|
791
Titan Machinery
TITN
$465M
| $1.56M | 0.02% |
118,296
+43,097
| +57% | +$641K |
|
792
Jazz Pharmaceuticals
JAZZ
$16.1B
| $1.54M | 0.02% |
+12,435
| New | +$1.84M |
|
793
Construction Partners
ROAD
$5.86B
| $1.54M | 0.02% |
174,419
+133,665
| +328% | +$1.3M |
|
|
AEL
794
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.53M | 0.02% |
+54,628
| New | +$1.76M |
|
795
BrightView Holdings
BV
$1.33B
| $1.52M | 0.02% |
+149,393
| New | +$1.92M |
|
796
Transocean
RIG
$5.84B
| $1.52M | 0.02% |
218,936
-1,238,232
| -85% | -$12.6M |
|
|
FOLD
797
DELISTED
Amicus Therapeutics
FOLD
| $1.51M | 0.02% |
158,090
-1,007,851
| -86% | -$11.1M |
|
798
Monster Beverage
MNST
$92.8B
| $1.5M | 0.02% |
+61,106
| New | +$1.66M |
|
|
ISBC
799
DELISTED
Investors Bancorp, Inc.
ISBC
| $1.5M | 0.02% |
144,428
-1,699,360
| -92% | -$19.6M |
|
|
CBIO
800
Crescent Biopharma
CBIO
$648M
| $1.5M | 0.02% |
+1,583
| New | +$1.9M |
|
Similar funds
Marshall Wace's Q4 2018 Portfolio in Review
As of Q4 2018, Marshall Wace held 1,967 positions worth $9.8B, down 17% from $11.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Marshall Wace's Q4 2018 filing shows 854 new, 344 increased, 350 reduced and 392 closed positions. Its largest new stake was Mastercard: 339,646 shares worth $64.1M. The largest sale was McDonald's, an estimated $140M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
- Marshall Wace's largest Q4 2018 buy was Mastercard: 339,646 shares worth $64.1M.
- Marshall Wace added most to Alphabet (Google) Class A in Q4 2018, an estimated $97.9M increase.
- Marshall Wace's biggest Q4 2018 reduction was McDonald's, cutting an estimated $140M.
- Marshall Wace fully exited Aetna Inc in Q4 2018, selling an estimated $77M.
- Marshall Wace's ten largest holdings make up 15% of its $9.8B portfolio in Q4 2018.
- Marshall Wace opened 854 new positions and closed 392 in Q4 2018.
- Marshall Wace's portfolio value fell 17% quarter-over-quarter to $9.8B.
Based on Marshall Wace's 13F filing for Q4 2018, filed 14 Feb 2019.